ATE422370T1 - Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe - Google Patents

Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe

Info

Publication number
ATE422370T1
ATE422370T1 AT03717407T AT03717407T ATE422370T1 AT E422370 T1 ATE422370 T1 AT E422370T1 AT 03717407 T AT03717407 T AT 03717407T AT 03717407 T AT03717407 T AT 03717407T AT E422370 T1 ATE422370 T1 AT E422370T1
Authority
AT
Austria
Prior art keywords
injectable composition
compound
same
composition containing
calcium phosphate
Prior art date
Application number
AT03717407T
Other languages
English (en)
Inventor
Bruno Bujoli
Solen Josse
Jerome Guicheux
Pascal Janvier
Jean-Michel Bouler
Guy Daculsi
Original Assignee
Centre Nat Rech Scient
Univ Nantes
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Nantes, Inst Nat Sante Rech Med filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE422370T1 publication Critical patent/ATE422370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03717407T 2002-03-04 2003-02-18 Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe ATE422370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0202707A FR2836681B1 (fr) 2002-03-04 2002-03-04 Compose phosphocalcique modifie, composition injectable le contenant

Publications (1)

Publication Number Publication Date
ATE422370T1 true ATE422370T1 (de) 2009-02-15

Family

ID=27741420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03717407T ATE422370T1 (de) 2002-03-04 2003-02-18 Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe

Country Status (10)

Country Link
US (2) US7521436B2 (de)
EP (1) EP1480687B1 (de)
JP (1) JP4248407B2 (de)
AT (1) ATE422370T1 (de)
AU (1) AU2003222575B2 (de)
CA (1) CA2477756C (de)
DE (1) DE60326122D1 (de)
ES (1) ES2322343T3 (de)
FR (1) FR2836681B1 (de)
WO (1) WO2003074098A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2836681B1 (fr) * 2002-03-04 2004-06-18 Centre Nat Rech Scient Compose phosphocalcique modifie, composition injectable le contenant
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7344716B2 (en) 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US8361467B2 (en) 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US8071574B2 (en) 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
WO2008005509A2 (en) * 2006-07-06 2008-01-10 Massachusetts Institute Of Technology Methods and compositions for altering biological surfaces
US8974801B2 (en) 2006-12-21 2015-03-10 Amphastar Pharmaceuticals Inc. Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
EP1958649A1 (de) * 2007-02-14 2008-08-20 Graftys Injizierbarer Kalzium-Phospat-Zement zur Freisetzung eines Knochenschwund-Inhibitors
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
WO2015135822A1 (en) * 2014-03-14 2015-09-17 Ecole Polytechnique Federale De Lausanne (Epfl) Active agent-particle combination supporting bone regeneration
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208234A (en) * 1992-03-10 1993-05-04 E. R. Squibb & Sons, Inc. Substituted imidazole phosphonic and phosphinic acid derivatives
FR2715853B1 (fr) * 1994-02-08 1996-04-26 Centre Nat Rech Scient Composition pour bio-matériau; procédé de préparation.
JP2002536123A (ja) * 1999-02-09 2002-10-29 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ 抗吸収性骨セメントならびに同種、自家、および異種骨移植片
FR2836681B1 (fr) * 2002-03-04 2004-06-18 Centre Nat Rech Scient Compose phosphocalcique modifie, composition injectable le contenant

Also Published As

Publication number Publication date
FR2836681A1 (fr) 2003-09-05
DE60326122D1 (de) 2009-03-26
US20050282783A1 (en) 2005-12-22
US20090203648A1 (en) 2009-08-13
JP2005531510A (ja) 2005-10-20
CA2477756C (fr) 2010-02-02
ES2322343T3 (es) 2009-06-19
JP4248407B2 (ja) 2009-04-02
WO2003074098A1 (fr) 2003-09-12
AU2003222575B2 (en) 2008-08-21
US7521436B2 (en) 2009-04-21
EP1480687A1 (de) 2004-12-01
US8044037B2 (en) 2011-10-25
FR2836681B1 (fr) 2004-06-18
EP1480687B1 (de) 2009-02-11
AU2003222575A1 (en) 2003-09-16
CA2477756A1 (fr) 2003-09-12

Similar Documents

Publication Publication Date Title
DE60326122D1 (de) Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe
BG105457A (en) Method for the preparation of citalopram
EA200500877A1 (ru) Получение блоков галогенидов редкоземельных металлов
CO6170362A2 (es) Procedimiento de preparacion de halogenuros de n-alquil-naltrexona
ATE321056T1 (de) Verfahren zur herstellung von mercaptoalkylalkoxysilanen
KR860000291A (ko) 결정성 칼슘 슈도모네이트의 제법
NO20055694L (no) Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav
DE50307001D1 (de) Verwendung von Schichtsilikat-Intercalationsverbindungen mit erhöhtem Expansionsvolumen als Brandschutzadditiv
DK1697326T3 (da) Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf
MX2022001785A (es) Proceso para preparar oxido de calcio o cemento pórtland normal a partir de rocas y minerales que llevan calcio.
IS6435A (is) Aðferð til framleiðslu á sítalóprami
NO974306L (no) Hydrogenperoksydkomplekser av uorganiske salter og syntese derav
ATE232508T1 (de) Umweltschonendes verfahren zur herstellung von natriumchloridkristallen
ZA200709019B (en) Fast-dissolving bentonite granulate
JP2007145708A5 (de)
EA200100095A1 (ru) Способ получения кальциевой соли зофеноприла
ATE486867T1 (de) Verfahren zur herstellung von hochreinem meloxicam und meloxicam-kaliumsalz
HUP0300227A2 (hu) Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
BRPI0402914A (pt) Método de produção de uma solução aquosa em concentração baixa de agente para o processamento de fibras sintéticas, solução aquosa em concentração baixa de agente, e, método de processamento de fibras sintéticas
DE50008920D1 (de) Verfahren zur herstellung von verbindungen der valproinsäure
BR112015003090B1 (pt) método para seletivamente inibir bactéria redutora de sulfato, composição de gesso capaz de inibir proliferação de bactéria redutora de sulfato pelo dito método, material de solificação do tipo gesso, e material de construção do tipo gesso
DE50008445D1 (de) Tricalciumphosphat-haltiges hydroxylapatit-material mit mikroporöser struktur
DE50109873D1 (de) Verfahren zur herstellung von 1-methyl-3-nitroguanidin
SE0302281D0 (sv) Novel compounds
AR053831A1 (es) Procedimiento para la preparacion de acido 5-halo -2,4,6-trifluoroisoftalico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1480687

Country of ref document: EP